Endocrinology Reading List

The Copyright law of the United States (Title 17, United States Code) governs the making of photocopies or other reproductions of copyright material. Under certain conditions specified in the law, libraries and archives are authorized to furnish a photocopy or other reproduction, which is not to be "used for any purposes other than private study, scholarship or research." If a user makes a request for, or later uses, a photocopy or reproduction for purposes in excess of "fair use", that user may be liable for copyright infringement.

• Harrison’s Principles of Internal Medicine, 16th edition, Braunwald et al, editors. McGraw-Hill, New York, 2005.
• Williams’ Textbook of Endocrinology. 10th edition. P. Reed Larsen et al, editors. Saunders, Philadelphia, 2003. [More pathophysiological/mechanistic orientation]
• Endocrinology. 5th edition. De Groot LJ & Jameson JL, editors, Saunders, Philadelphia, 2006. [Comprehensive]
  Location: Galter Library Reserve Desk WK 140 E56 2006
• Ellenberg & Rifkin’s Diabetes Mellitus, 6th edition. Daniel Porte, Jr., Robert S Sherwin, Alain Baron (eds.), McGraw-Hill, New York, NY, 2003.
  Location: Galter Library Reserve Desk WK 810 E45 2003
  Location: NMH Health Learning Center WK 810 E45 2003
• Endocrinology and Metabolism Clinics of North America. [This is a periodical book series available online through MD Consult and in print at the Galter Library. Each volume is focused on a specific topic. Topics are updated frequently. Clinically oriented.]
  

• Standards of medical care for patients with diabetes mellitus. Diabetes Care 2006;29 (Suppl. 1):S4-S42.
• The Diabetes control and complications trial (DCCT) group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-986.
• The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCTT/EDIC) Research Group. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes. NEJM 2005;353:2643-53.
• DeFronzo RA.  Pathogenesis of type 2 diabetes mellitus.  Med Clin North Am. 2004; 88:787-835, ix. (No direct link to article available. Click on link above, enter DeFronzo in the author field on the left of the screen and click Search.)
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346(6):393-403.
• Turner RC. The UK prospective diabetes study. A review. Diabetes Care 1998;21(Suppl 3):C35-C38. (Not available electronically; available in print at Galter Library.)
• DeFronzo RA. Pharmacologic therapy for type 2 diabetes. Ann Int Med 1999;131(4):281-303.
• Hirsch IB.  Insulin analogues.  N Engl J Med. 2005; 352:174-83.
• DeWitt DE, Hirsch IB.  Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA. 2003 289:2254-64.
• Molitch M.  Management of Dyslipidemias in Patients with Diabetes and Chronic Kidney Disease.  Clin J Am Soc Nephrol 2006; 1:1090-1099
• Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P. Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345(19):1359-1367.
• Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345(13):971-980.
• Ford ES, Giles WH, Mokdad AH.  Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults.  Diabetes Care 2004; 27:2444-2449.
• Mokdad AH, Ford ES, Bowman BA, Dietz WH, et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.  JAMA 2003; 289:76-79.
• Executive Summary of the third report of the national cholesterol education program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(19): 2486-2509.
• Stone NJ, Bilek S, Rosenbaum S.  Recent National Cholesterol Education Program Adult Treatment Panel III Update: Adjustments and Options.  Am J Cardiol 2005; 96[suppl]:53E-59E.
• Grundy SM, Cleeman JI, Merz CN, et al.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.  Circulation 2004; 110:227-239.

• Hegedus L.  The Thyroid Nodule.  N Engl J Med 2004; 351:1764-1771.
• Alexander EK, Hurwitz S, Heering J, et al.  Natural History of Benign Sold and Cystic Thyroid Nodules.  Ann Intern Med 2003; 138:315-318.
• Tan GH, Gharib H. Thyroid incidentalomas: mangement approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Int Med 1997;126(3);226-231.
• Weetman AP. Graves' disease. N Engl J Med 2000;343(17):1236-1248
• Burch HB, Wartofsky L. Life-threatening thyrotoxicosis - Thyroid storm. Endocrinol Metab Clinics of N America 1993; 22:263-277. (Not available electronically; available in print at Galter Library.)
• Cooper DS.  Antithyroid Drugs.  N Engl J Med 2005; 352:905-917.
• Roberts CG, Ladenson PW.  Hypothyroidism.  Lancet 2004; 363:793-803.
• Alexander EK, Marqusee E, Lawrence J, et al.  Timing and Magnitude of Increases in Levothyroxine Requirements during Pregnancy in Women with Hypothyroidism.  N Engl J Med 2004; 351:241-249.
• Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996;335(2):99-106.
• Basaria S, Cooper DS.  Amiodarone and the thyroid.  Am J Med 2005; 118:706-714.
• Stathatos N, Wartofsky L.  The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment?  J Endocrinol Invest 2003; 26(12) :1174-9. (No direct link to article; click on link and search for article in previous issues section.)
• Burman KD, Wartofsky L. Thyroid function in the intensive care unit setting. Crit Care Clin 2001;17(1):43-57. (No direct link to article available. Click on link above, enter Burman in the author field on the left of the screen and click Search.)
• Ladenson PW, Peter A. Singer, Kenneth B. Ain, Nandalal Bagchi, S. Thomas Bigos, Elliot G. Levy, Steven A. Smith, Gilbert H. Daniels. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000;160(11):1573-1575.
• Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, et al.  The American Thyroid Association Guidelines Taskforce.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.  Thyroid 2006; 16: 109-142.
• Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 88:1433-41, 2003.
• Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338(5):297-306.
  

• Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343(25):1863-1875.
• Bilezikian JP, Potts, J., jr., Fuleihan E, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells S. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 2002;87(12)5353-5361
• Strewler GJ. The physiology of parathyroid hormone-related protein. N Engl J Med 2000;342(3):177-185.
• Silverberg SJ, Shane E, Jacob TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999;341(17):1249-1255.
• Hodgson SF et al., American Association of Clinical Endocrinologists' 2001 Medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis (2003 revision). Endocr Pract 2003;9(6):544-564.
• Shea B, Wells G, et al.  Meta-analyses of therapies for postmenopausal osteoporosis.  VII.  Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis.  Endocr Rev 2002; 23:552-559.
• Bischoff-Ferrari HA, Willett WC, et al.  Fracture Prevention with Vitamin D supplementation: a meta-analysis of randomized controlled trials.  JAMA 2005; 293:2257-2264.
• McClung MR.  Bisphosphonates.  Endocrinol Metab Clin North Am 2003; 32:253-271. (No direct link to article available. Click on link above, enter McClung in the author field on the left of the screen and click Search.)
• Hodsman AB, Bauer DC, et al.  Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.  Endocr Rev 2005; 26:688-703.
• Saag K.  Glucocorticoid-induced osteoporosis.  Endocrinol Metab Clin North Am 2003; 32:135-157. (No direct link to article available. Click on link above, enter Saag in the author field on the left of the screen and click Search.)
• Siris ES. Goals of treatment for Paget's disease of bone. J Bone Miner Res. 1999;14(Suppl 2):49-52.
• Reid IR, Miller P, et al.  Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget’s Disease.  N Engl J Med 2005; 353:898-908.
• Hoff AO, Cote GJ, Gagel RF. Multiple endocrine neoplasias. Annu Rev Physiol 2000;62(1):377-411.

• Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab 2006;91:1621-1634. 
• Colao A, Ferone D, Marzullo P, Lombardi G.  Systemic complications of acromegaly: epidemiology, pathogenesis, and management.  Endocrine Rev 2004;25:102-152
• Strasburger CA et al.  Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of The Growth Hormone Research Society and The Pituitary Society.  J Clin Endocrinol Metab 2004;89:3099-3104.
• Holdaway IM, Rajasoorya RC, Gamble GD.  Factors influencing mortality in acromegaly.  J Clin Endocrinol Metab 89:667-674, 2004.
• Clemmons DR, Chihara K, Freda PU et al.  Optimizing control of acromegaly : integrating a growth hormone receptor antagonist into the treatment algorithm.  J Clin Endocrinol Metab 88:4759-4767, 2003.
• Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M,  Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho L, Wass J, Giustina A. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.  Clin Endocrinol.  2006;65:265-273.
• Gillam MP, Molitch MP, Lombardi G, Colao A. Advances in the treatment of prolactinomas.  Endocrine Revs 2006;27:485-534.
• Lindsay JR, Nieman LK.  The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment.  Endocr Rev 2005;26:775-799.
• Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB.  Transsphenoidal microsurgery for Cushing’s Disease: initial outcome and long-term results.  J Clin Endocrinol Metab 2004;89:6348-6357.
• Sheehan JP, Niranjan A, Sheehan JM, Jane JA, Laws ER, Kondziolka D, Flickinger J, Landolt AM, Loeffler JS, Lunsford LD.  Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium.  J Neurosurg 2005;102:678-691.
• Agha A, Rogers B, Sherlock M, O’Kelly P, Tormey W, Phillips J, Thompson CJ.  Anterior pituitary dysfunction in survivors of traumatic brain injury.  J Clin Endocrinol Metab 2004;89:4929-4936.
• Agha A, Sherlock M, Brennan S, O’Connor SA, O’Sullivan E et al.  Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults.  J Clin Endocrinol Metab 2005;90;6355-6360.
• Reynolds RM, Seckl JR.  Hyponatraemia for the clinical endocrinologist. Clin Endocrinol.  2005;63:366-374. 

• Hamrahian AH, Oseni TS, Arafah BM.  Measurements of serum free cortisol in critically ill patients.  N Engl J Med. 2004;350:1629-38.
• Sam S, Corbridge TC, Mokhlesi B, Comellas, AP, Molitch ME.  Cortisol levels and mortality in severe sepsis.  Clin Endocrinol 2004; 60:29-35.
• Annane D, Sebille V, Troche G, Raphael JC, et al.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.  JAMA 2000; 283:1038-1045.
• Arnaldi G, Angeli A, et al.  Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement.  J Clin Endocrinol Metab 2003; 88:5593-5602.
• Findling JW and Raff H.  Cushing’s Syndrome: Important Issues in Diagnosis and Management.  J Clin Endocrinol Metab 2006; 91: 3746-3753.
• Ten S, New M, MacLaren N. Addison's disease 2001. J Clin Endocrinol Metab 2001;86(7):2909-2922.
• Ganguly A. Primary aldosteronism. N Engl J Med 1998;339(25):1828-1834.
• Hamrahian AH et al. Clinical Utility of Noncontrast CT Attenuation Value (Hounsfield units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas.  J Clin Endocrinol Metab 2005; 90:871-877.
• Young WF Jr.  Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota.  Endocrinol Metab Clin North Am. 2000; 29:159-185. (No direct link to article available. Click on link above, enter Young in the author field on the left of the screen and click Search.)
• Jimenez C, Cote G, et al.  Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?  J Clin Endocrinol Metab 2006; 91:2851-8.
  

• Bhasin S, Cunnigham GR, Hayes FJ, et al.  Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab 2006; 91:1995-2010.
• Wierman ME, Basson R, Davis SR, et al.  Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab 2006; 91:3697-3710.
• Reed SD, Newton KM, and LaCroix AZ.  Indications for Hormone Therapy: The Post-Women’s Health Initiative Era.  Endocrinol Metab Clin North Am 2004; 33:691-715. (No direct link to article available. Click on link above, enter Reed in the author field on the left of the screen and click Search.)
• Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Ann Rev Med 2001;52(1):401-419.
• Dunaif A.  Insulin Resistance in women with polycystic ovary syndrome.  Fertil Steril 2006 86 Suppl 1:S13-4.
• Sybert VP, McCauley E.  Turner's syndrome.  N Engl J Med 2004; 351:1227-38.
• Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E.  Klinefelter’s syndrome.  Lancet 2004; 364:273-283. 

Galter Health Sciences Library · Feinberg School of Medicine · Northwestern University
303 E. Chicago Avenue · Chicago, IL 60611-3008
Phone 312-503-8126 · Fax 312-503-1204
Copyright © 1999-2006 Northwestern University. World Wide Web Disclaimer and University Policy Statements

38.103.63.16